These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 880261)

  • 1. Persistent effects of repeated injections of D-lysergic acid diethylamide on rat brain 5-hydroxytryptamine and 5-hydroxyindoleacetic acid levels.
    Peters DA; Tang S
    Biochem Pharmacol; 1977 Jun; 26(11):1085-6. PubMed ID: 880261
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistent increase in brain serotonin turnover after chronic administration of LSD in the rat.
    Díaz JL; Huttunen MO
    Science; 1971 Oct; 174(4004):62-4. PubMed ID: 5120868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of altered brain 5-hydroxytryptaminergic activity on brain tryptophan, 5-hydroxytryptamine and 5-hydroxyindoleacetic acid.
    Marsden CA; Curzon G
    Neuropharmacology; 1976 Nov; 15(11):703-8. PubMed ID: 1004692
    [No Abstract]   [Full Text] [Related]  

  • 4. Lysergic acid diethylamide: role in conversion of plasma tryptophan to brain serotonin (5-hydroxytryptamine).
    Lin RC; Ngai SH; Costa E
    Science; 1969 Oct; 166(3902):237-9. PubMed ID: 5809595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of immobilization on rat liver tryptophan pyrrolase and brain 5-hydroxytryptamine metabolism.
    Curzon G; Green AR
    Br J Pharmacol; 1969 Nov; 37(3):689-97. PubMed ID: 5348471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of some hallucinogenic drugs upon the metabolism of 5-hydroxy-tryptamine in the brain.
    Tonge SR; Leonard BE
    Life Sci; 1969 Aug; 8(15):805-14. PubMed ID: 5807313
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of lysergic acid diethylamide on the uptake and retention of brain 5-hydroxytryptamine in vivo and in vitro.
    Ziegler MG; Lovell RA; Freedman DX
    Biochem Pharmacol; 1973 Sep; 22(17):2183-93. PubMed ID: 4270151
    [No Abstract]   [Full Text] [Related]  

  • 8. Brain serotonin metabolism after tolerance dosage of LSD.
    Freedman DX; Boggan WO
    Adv Biochem Psychopharmacol; 1974; 10():151-7. PubMed ID: 4846536
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of chlorimipramine and lysergic acid diethylamide on efflux of precursor-formed 3-H-serotonin: correlations with serotonergic impulse flow.
    Gallager DW; Aghajanian GK
    J Pharmacol Exp Ther; 1975 Jun; 193(3):785-95. PubMed ID: 168347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the chronic and acute effects of D-lysergic acid diethylamide (LSD) treatment on rat brain serotonin and norepinephrine.
    Peters DA
    Biochem Pharmacol; 1974 Jan; 23(2):231-7. PubMed ID: 4149793
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic lysergic acid diethylamide administration and serotonin turnover in various regions of the rat brain.
    Peters DA
    J Neurochem; 1974 Oct; 23(4):625-8. PubMed ID: 4430908
    [No Abstract]   [Full Text] [Related]  

  • 12. Reversal learning enhanced by lysergic acid diethylamide (LSD): concomitant rise in brain 5-hydroxytryptamine levels.
    King AR; Martin IL; Melville KA
    Br J Pharmacol; 1974 Nov; 52(3):419-26. PubMed ID: 4458849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lisuride- and D-LSD-induced changes of monoamine turnover in the rat brain.
    Keller HH; Burkard WP; Pieri L; Bonetti EP; Da Prada M
    Adv Biochem Psychopharmacol; 1978; 19():393-6. PubMed ID: 696467
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of brain 5-hydroxytryptamine in the central action of L-DOPA.
    Maj J; Pawlowski L; Sarnek J
    Adv Biochem Psychopharmacol; 1974; 10():253-6. PubMed ID: 4846541
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of lysergic acid diethylamide on the metabolism of brain 5-hydroxytryptamine.
    Rosecrans JA; Lovell RA; Freedman DX
    Biochem Pharmacol; 1967 Oct; 16(10):2011-21. PubMed ID: 6065966
    [No Abstract]   [Full Text] [Related]  

  • 16. Some metabolic and behavioural effects of LSD.
    Kabes J; Fink Z; Somlev A; Vrba J; Mádlo Z
    Act Nerv Super (Praha); 1972 Nov; 14(4):294-5. PubMed ID: 5083833
    [No Abstract]   [Full Text] [Related]  

  • 17. The relation between cerebral serotonin levels and conditioned behaviour in the rat following the administration of LSD-25 and UML.
    Torre M; Torre E; Bogetto F
    Psychopharmacologia; 1975; 41(3):245-7. PubMed ID: 1153613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain monoamines in guinea pigs with experimental allergic encephalitis.
    Lycke E; Roos BE
    Int Arch Allergy Appl Immunol; 1973; 45(3):341-51. PubMed ID: 4126541
    [No Abstract]   [Full Text] [Related]  

  • 19. Behavioral reaction of rats pretreated with reserpine to LSD-25.
    Votava Z; Glisson SN; Himwich HE
    Int J Neuropharmacol; 1967 Nov; 6(6):543-7. PubMed ID: 5586670
    [No Abstract]   [Full Text] [Related]  

  • 20. The actions of neuroleptic drugs and putative serotonin receptor antagonists on LSD and quipazine-induced reductions of brain 5-HIAA concentrations.
    Jacoby JH; Poulakos JJ
    J Pharm Pharmacol; 1977 Dec; 29(12):771-3. PubMed ID: 22629
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.